BSE Live
Jan 20, 16:01Prev. Close
770.20
Open Price
769.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 20, 15:59Prev. Close
769.80
Open Price
769.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
765.15 (23)
| Cash Flow of Alembic Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 608.59 | 704.23 | 345.93 | 658.01 | 1,416.60 | |
| Net CashFlow From Operating Activities | 226.57 | 772.77 | 730.25 | 545.26 | 1,485.30 | |
| Net Cash Used In Investing Activities | -636.08 | -329.02 | -460.98 | -368.72 | -925.55 | |
| Net Cash Used From Financing Activities | 403.61 | -445.29 | -261.16 | -216.64 | -533.60 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | -0.93 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -5.90 | -1.54 | 8.11 | -40.10 | 25.22 | |
| Cash And Cash Equivalents Begin of Year | 20.13 | 21.67 | 13.56 | 53.66 | 28.22 | |
| Cash And Cash Equivalents End Of Year | 14.23 | 20.13 | 21.67 | 13.56 | 53.44 |
17.11.2025
Alembic Pharma shares gain 2% on USFDA nod for Diltiazem Hydrochloride tablets
17.11.2025
10.11.2025
Alembic Pharma Standalone September 2025 Net Sales at Rs 1,796.24 crore, up 13.66% Y-o-Y
07.11.2025
Alembic Pharma Consolidated September 2025 Net Sales at Rs 1,910.15 crore, up 15.91% Y-o-Y
10.11.2025
Alembic Pharma Standalone September 2025 Net Sales at Rs 1,796.24 crore, up 13.66% Y-o-Y
07.11.2025
Alembic Pharma Consolidated September 2025 Net Sales at Rs 1,910.15 crore, up 15.91% Y-o-Y
12.08.2025
Alembic Pharma Consolidated June 2025 Net Sales at Rs 1,710.72 crore, up 9.54% Y-o-Y
05.08.2025
Alembic Pharma Standalone June 2025 Net Sales at Rs 1,494.17 crore, up 1.26% Y-o-Y
19.10.2021
Alembic Pharma Q2 PAT may dip 49.2% YoY to Rs 169.4 cr: ICICI Direct
13.07.2021
Alembic Pharmaceuticals Q1 PAT may dip 28.7% YoY to Rs 215 cr: KRChoksey
12.07.2021
Alembic Pharma Q1 PAT may dip 20.3% YoY to Rs 240.2 cr: ICICI Direct
18.01.2021
Alembic Pha Q3 PAT seen up 19.9% YoY to Rs. 280.9 cr: ICICI Direct